Company Filing History:
Years Active: 2015
Title: Anja Krippner-Heidenreich: Innovator in Recombinant Polypeptides
Introduction
Anja Krippner-Heidenreich is a prominent inventor based in Newcastle upon Tyne, GB. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. Her work focuses on innovative solutions for treating diseases and advancing medical research.
Latest Patents
Anja holds a patent for "Recombinant polypeptides of the members of the TNF ligand family and use thereof." This invention relates to polypeptides that consist of at least three monomers of a member of the TNF ligand family, linked by at least two peptide linkers. The applications of these polypeptides include their use in treating diseases and in the production of medicaments or vaccines. Additionally, her patent encompasses methods for producing and isolating these polypeptides, as well as the nucleic acids that code for them. The invention also includes vectors containing these nucleic acids and host cells transfected with these vectors. Furthermore, it addresses pharmaceutical compositions that incorporate these innovative polypeptides and methods for extracorporeal manipulation of components in body fluids.
Career Highlights
Anja Krippner-Heidenreich is affiliated with the University of Stuttgart, where she continues her research and development in biotechnology. Her work has garnered attention for its potential impact on medical treatments and vaccine development.
Collaborations
Throughout her career, Anja has collaborated with notable colleagues, including Klaus Pfizenmaier and Peter Scheurich. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.
Conclusion
Anja Krippner-Heidenreich is a trailblazer in the field of recombinant polypeptides, with a focus on innovative medical applications. Her contributions are paving the way for future advancements in biotechnology and healthcare.